FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076035263> ?p ?o ?g. }

• W2076035263 endingPage "313" @default.
• W2076035263 startingPage "308" @default.
• W2076035263 abstract "The present treatment for acute attacks of headache is empiric. Intramuscular nalbuphine (Nubain®) and hydroxyzine (Vistaril®) were assessed for pain relief in a prospective, double-blind clinical trial. Ninety-four patients were assigned randomly to treatment groups receiving nalbuphine 10 mg, nalbuphine 10 mg plus hydroxyzine 50 mg, hydroxyzine 50 mg, or placebo. The treatment groups were found to be adequately homogenous with regard to age, sex, type and duration of headaches, and history of prior narcotic use. All data were analyzed by one-way analysis of variance. Patients who had headaches diagnosed as other than classic migraine had significantly greater pain relief with nalbuphine compared to placebo (P < .01). The combination of nalbuphine and hydroxyzine was not significantly more effective than other treatment groups. In 20 patients with classic migraine, none of the treatment regimens significantly outperformed placebo. There were no clinically significant adverse effects attributed to the study drugs. These findings are similar to others that showed a lack of efficacy of kappa receptor agonists in classic migraineurs. Nalbuphine appears to be clinically useful in other types of severe headache. This study does not support the routine addition of hydroxyzine for presumed synergistic effect. The present treatment for acute attacks of headache is empiric. Intramuscular nalbuphine (Nubain®) and hydroxyzine (Vistaril®) were assessed for pain relief in a prospective, double-blind clinical trial. Ninety-four patients were assigned randomly to treatment groups receiving nalbuphine 10 mg, nalbuphine 10 mg plus hydroxyzine 50 mg, hydroxyzine 50 mg, or placebo. The treatment groups were found to be adequately homogenous with regard to age, sex, type and duration of headaches, and history of prior narcotic use. All data were analyzed by one-way analysis of variance. Patients who had headaches diagnosed as other than classic migraine had significantly greater pain relief with nalbuphine compared to placebo (P < .01). The combination of nalbuphine and hydroxyzine was not significantly more effective than other treatment groups. In 20 patients with classic migraine, none of the treatment regimens significantly outperformed placebo. There were no clinically significant adverse effects attributed to the study drugs. These findings are similar to others that showed a lack of efficacy of kappa receptor agonists in classic migraineurs. Nalbuphine appears to be clinically useful in other types of severe headache. This study does not support the routine addition of hydroxyzine for presumed synergistic effect." @default.
• W2076035263 created "2016-06-24" @default.
• W2076035263 creator A5035967555 @default.
• W2076035263 creator A5085304002 @default.
• W2076035263 date "1987-03-01" @default.
• W2076035263 modified "2023-10-06" @default.
• W2076035263 title "The effectiveness of nalbuphine and hydroxyzine for the emergency treatment of severe headache" @default.
• W2076035263 cites W1541198047 @default.
• W2076035263 cites W1971780160 @default.
• W2076035263 cites W1975185813 @default.
• W2076035263 cites W1982762361 @default.
• W2076035263 cites W1987132814 @default.
• W2076035263 cites W1987833538 @default.
• W2076035263 cites W1988497216 @default.
• W2076035263 cites W1992846972 @default.
• W2076035263 cites W1994349089 @default.
• W2076035263 cites W1997979551 @default.
• W2076035263 cites W2010015625 @default.
• W2076035263 cites W2011534717 @default.
• W2076035263 cites W2011990892 @default.
• W2076035263 cites W2013314905 @default.
• W2076035263 cites W2013405740 @default.
• W2076035263 cites W2017077318 @default.
• W2076035263 cites W2036319185 @default.
• W2076035263 cites W2047622645 @default.
• W2076035263 cites W2049973545 @default.
• W2076035263 cites W2055321179 @default.
• W2076035263 cites W2056272282 @default.
• W2076035263 cites W2060001137 @default.
• W2076035263 cites W2063136461 @default.
• W2076035263 cites W2077130781 @default.
• W2076035263 cites W2077232090 @default.
• W2076035263 cites W2084198621 @default.
• W2076035263 cites W2087239004 @default.
• W2076035263 cites W2098957364 @default.
• W2076035263 cites W2110378146 @default.
• W2076035263 cites W2124421414 @default.
• W2076035263 cites W2142314814 @default.
• W2076035263 cites W2171173665 @default.
• W2076035263 cites W2320318607 @default.
• W2076035263 cites W2345247159 @default.
• W2076035263 cites W2418496947 @default.
• W2076035263 cites W2805730435 @default.
• W2076035263 cites W3024861960 @default.
• W2076035263 cites W4230802620 @default.
• W2076035263 cites W4241589160 @default.
• W2076035263 doi "https://doi.org/10.1016/s0196-0644(87)80177-4" @default.
• W2076035263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3544982" @default.
• W2076035263 hasPublicationYear "1987" @default.
• W2076035263 type Work @default.
• W2076035263 sameAs 2076035263 @default.
• W2076035263 citedByCount "14" @default.
• W2076035263 countsByYear W20760352632012 @default.
• W2076035263 countsByYear W20760352632013 @default.
• W2076035263 countsByYear W20760352632014 @default.
• W2076035263 countsByYear W20760352632016 @default.
• W2076035263 countsByYear W20760352632017 @default.
• W2076035263 countsByYear W20760352632023 @default.
• W2076035263 crossrefType "journal-article" @default.
• W2076035263 hasAuthorship W2076035263A5035967555 @default.
• W2076035263 hasAuthorship W2076035263A5085304002 @default.
• W2076035263 hasConcept C126322002 @default.
• W2076035263 hasConcept C141071460 @default.
• W2076035263 hasConcept C142724271 @default.
• W2076035263 hasConcept C170493617 @default.
• W2076035263 hasConcept C204787440 @default.
• W2076035263 hasConcept C27081682 @default.
• W2076035263 hasConcept C2776246316 @default.
• W2076035263 hasConcept C2778977083 @default.
• W2076035263 hasConcept C2780966972 @default.
• W2076035263 hasConcept C2781063702 @default.
• W2076035263 hasConcept C42219234 @default.
• W2076035263 hasConcept C71924100 @default.
• W2076035263 hasConceptScore W2076035263C126322002 @default.
• W2076035263 hasConceptScore W2076035263C141071460 @default.
• W2076035263 hasConceptScore W2076035263C142724271 @default.
• W2076035263 hasConceptScore W2076035263C170493617 @default.
• W2076035263 hasConceptScore W2076035263C204787440 @default.
• W2076035263 hasConceptScore W2076035263C27081682 @default.
• W2076035263 hasConceptScore W2076035263C2776246316 @default.
• W2076035263 hasConceptScore W2076035263C2778977083 @default.
• W2076035263 hasConceptScore W2076035263C2780966972 @default.
• W2076035263 hasConceptScore W2076035263C2781063702 @default.
• W2076035263 hasConceptScore W2076035263C42219234 @default.
• W2076035263 hasConceptScore W2076035263C71924100 @default.
• W2076035263 hasIssue "3" @default.
• W2076035263 hasLocation W20760352631 @default.
• W2076035263 hasLocation W20760352632 @default.
• W2076035263 hasOpenAccess W2076035263 @default.
• W2076035263 hasPrimaryLocation W20760352631 @default.
• W2076035263 hasRelatedWork W1832609591 @default.
• W2076035263 hasRelatedWork W1973951111 @default.
• W2076035263 hasRelatedWork W2010519611 @default.
• W2076035263 hasRelatedWork W2076035263 @default.
• W2076035263 hasRelatedWork W2129862555 @default.
• W2076035263 hasRelatedWork W2398996684 @default.
• W2076035263 hasRelatedWork W2462681278 @default.
• W2076035263 hasRelatedWork W2554635175 @default.

• next